Hongjie Zhu

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuel Bachy, Kerry Joane Savage, Huiqiang Huang, Yok-Lam L Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Hai-Yan Yang, Siguo Hao, Jianda Hu, Ke-Shu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José Maria Ferreri, Gandhi Laurent Damaj, Wei Zhang, Hui Liu, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason C Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Luigi Zinzani
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open label phase 2 study. Blood advances (2023)
Constantine S Tam, Meletios A Dimopoulos, Ramon Garcia-Sanz, Judith Trotman, Stephen Opat, Andrew W Roberts, Roger G Owen, Yuqin Song, Wei Xu, Jun Zhu, Jianyong Li, Lugui Qiu, Shirley D'Sa, Wojciech Jurczak, Gavin Cull, Paula Marlton, David J Gottlieb, Javier Munoz, Tycel Phillips, Chenmu Du, Meng Ji, Lei Zhou, Haiyi Guo, Hongjie Zhu, Wai Y Chan, Aileen Cohen, William Novotny, Jane Huang, Alessandra Tedeschi
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood advances (2021)

Hongjie Zhu.css-eqlu8i{font-size:small;padding-left:4px;}